- $304.51m
- $478.50m
- $114.20m
U.S. RESEARCH ROUNDUP- Lennar, Republic Services, Ulta Beauty
Agenus Inc reports results for the quarter ended in December - Earnings Summary
Brief: Agenus Reports Fourth Quarter And Full Year 2023 Results
Agenus Inc expected to post a loss of 5 cents a share - Earnings Preview
Brief: Agenus Inc - Proposing A Reverse Stock Split At A Ratio Of 1-For-20
Brief: Ginkgo Bio, SaponiQx Awarded MCDC Contract To Discover And Manufacture Next-Generation Vaccine Adjuvants
Brief: Botensilimab/Balstilimab Breakthrough Data Presented At Asco-Gi Shows Unprecedented Tumor Shrinkage And Robust Biomarker Response In Prevalent Colorectal Cancer Population
Brief: Agenus To Receive $25 Mln Milestone Payment From Bristol Myers Squibb For TIGIT-CD96 Bispecific Program
Brief: Agenus QTRLY Loss Per Share $0.16
Agenus Inc expected to post a loss of 19 cents a share - Earnings Preview
Brief: Agenus Unveils New And Updated Botensilimab Data In Colorectal, Pancreatic, Lung, Melanoma, And Sarcoma
Brief: Agenus Completes Enrollment In Randomized Phase 2 Clinical Trial Of Botensilimab/Balstilimab In Advanced Colorectal Cancer
Agenus falls after announcing cost-saving plans, job cuts
Brief: Agenus Prioritizes Resources To Accelerate Registration And Commercialization Of Bot/Bal Program In Multiple Cancers
Agenus Inc reports results for the quarter ended in June - Earnings Summary
Brief: Agenus Reports Second Quarter 2023 Results
Agenus Inc expected to post a loss of 20 cents a share - Earnings Preview
Brief: Agenus Expands Executive Leadership Team
Agenus Inc reports results for the quarter ended in March - Earnings Summary